An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...
Jun 6, 2022
0
7
A controversy in the scientific community over recent claims anti-depressants can be ineffective at treating depression has highlighted the difficulties in understanding mental health conditions.
Aug 11, 2022
0
19
(HealthDay)—Daridorexant (50 mg) improves both nighttime symptoms and daytime functioning in people with insomnia disorder, according to a study published in the Feb. 1 issue of The Lancet Neurology.
Feb 4, 2022
0
7
As many as 90 percent of promising drug candidates fail before or during human clinical trials, falling into the so-called "valley of death."
Mar 16, 2020
0
105
In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...
Apr 13, 2020
0
4
(HealthDay)—Long-term antidepressant use increases the risk for type 2 diabetes onset in a time- and dose-dependent manner, according to a study published online Feb. 12 in Diabetes Care.
Feb 25, 2020
0
38
Maternal genetic liability to neurodevelopmental conditions is associated with several pregnancy-related factors previously thought to be associated with those conditions, according to a study published online July 6 in JAMA ...
Jul 13, 2022
0
3
Prenatal exposure to topiramate, valproate, and certain duotherapies is associated with increased risks for autism spectrum disorder (ASD) and intellectual disability (ID), according to a study published online May 31 in ...
May 31, 2022
0
1
For more than 20 years now, international research into the endocannabinoid system in the human body has been seeking to understand the mode of action of cannabis and its constituents. There is ample evidence of therapeutic ...
Dec 17, 2021
1
129
Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
Aug 2, 2023
0
52
